339 related articles for article (PubMed ID: 26461091)
1. Adult Lineage-Restricted CNS Progenitors Specify Distinct Glioblastoma Subtypes.
Alcantara Llaguno SR; Wang Z; Sun D; Chen J; Xu J; Kim E; Hatanpaa KJ; Raisanen JM; Burns DK; Johnson JE; Parada LF
Cancer Cell; 2015 Oct; 28(4):429-440. PubMed ID: 26461091
[TBL] [Abstract][Full Text] [Related]
2. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
[TBL] [Abstract][Full Text] [Related]
3. Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma.
Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; dePinho RA
Cold Spring Harb Symp Quant Biol; 2008; 73():427-37. PubMed ID: 19150964
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells.
Koga T; Chaim IA; Benitez JA; Markmiller S; Parisian AD; Hevner RF; Turner KM; Hessenauer FM; D'Antonio M; Nguyen ND; Saberi S; Ma J; Miki S; Boyer AD; Ravits J; Frazer KA; Bafna V; Chen CC; Mischel PS; Yeo GW; Furnari FB
Nat Commun; 2020 Jan; 11(1):550. PubMed ID: 31992716
[TBL] [Abstract][Full Text] [Related]
5. Of Brains and Blood: Developmental Origins of Glioma Diversity?
Filbin MG; Stiles CD
Cancer Cell; 2015 Oct; 28(4):403-404. PubMed ID: 26461085
[TBL] [Abstract][Full Text] [Related]
6. Cell of Origin and Cancer Stem Cells in Tumor Suppressor Mouse Models of Glioblastoma.
Alcantara Llaguno SR; Xie X; Parada LF
Cold Spring Harb Symp Quant Biol; 2016; 81():31-36. PubMed ID: 27815542
[TBL] [Abstract][Full Text] [Related]
7. Olig1/2-Expressing Intermediate Lineage Progenitors Are Predisposed to PTEN/p53-Loss-Induced Gliomagenesis and Harbor Specific Therapeutic Vulnerabilities.
Verma R; Chen X; Xin D; Luo Z; Ogurek S; Xin M; Rao R; Berry K; Lu QR
Cancer Res; 2023 Mar; 83(6):890-905. PubMed ID: 36634201
[TBL] [Abstract][Full Text] [Related]
8. Genomic landscape of gliosarcoma: distinguishing features and targetable alterations.
Zaki MM; Mashouf LA; Woodward E; Langat P; Gupta S; Dunn IF; Wen PY; Nahed BV; Bi WL
Sci Rep; 2021 Sep; 11(1):18009. PubMed ID: 34504233
[TBL] [Abstract][Full Text] [Related]
9. Radiation-Induced DNA Damage Cooperates with Heterozygosity of TP53 and PTEN to Generate High-Grade Gliomas.
Todorova PK; Fletcher-Sananikone E; Mukherjee B; Kollipara R; Vemireddy V; Xie XJ; Guida PM; Story MD; Hatanpaa K; Habib AA; Kittler R; Bachoo R; Hromas R; Floyd JR; Burma S
Cancer Res; 2019 Jul; 79(14):3749-3761. PubMed ID: 31088835
[TBL] [Abstract][Full Text] [Related]
10. Cell-of-origin susceptibility to glioblastoma formation declines with neural lineage restriction.
Alcantara Llaguno S; Sun D; Pedraza AM; Vera E; Wang Z; Burns DK; Parada LF
Nat Neurosci; 2019 Apr; 22(4):545-555. PubMed ID: 30778149
[TBL] [Abstract][Full Text] [Related]
11. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
[TBL] [Abstract][Full Text] [Related]
12. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
[TBL] [Abstract][Full Text] [Related]
13. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.
Gao X; Jin W
Cancer Lett; 2014 Oct; 353(1):25-31. PubMed ID: 25042866
[TBL] [Abstract][Full Text] [Related]
14. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
15. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
[TBL] [Abstract][Full Text] [Related]
16. C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells.
Guo P; Nie Q; Lan J; Ge J; Qiu Y; Mao Q
Biochem Biophys Res Commun; 2013 Nov; 441(1):186-90. PubMed ID: 24140063
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma.
Shiras A; Chettiar ST; Shepal V; Rajendran G; Prasad GR; Shastry P
Stem Cells; 2007 Jun; 25(6):1478-89. PubMed ID: 17332509
[TBL] [Abstract][Full Text] [Related]
18. Comparative genomic and genetic analysis of glioblastoma-derived brain tumor-initiating cells and their parent tumors.
Davis B; Shen Y; Poon CC; Luchman HA; Stechishin OD; Pontifex CS; Wu W; Kelly JJ; Blough MD;
Neuro Oncol; 2016 Mar; 18(3):350-60. PubMed ID: 26245525
[TBL] [Abstract][Full Text] [Related]
19. Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes.
Jacques TS; Swales A; Brzozowski MJ; Henriquez NV; Linehan JM; Mirzadeh Z; O' Malley C; Naumann H; Alvarez-Buylla A; Brandner S
EMBO J; 2010 Jan; 29(1):222-35. PubMed ID: 19927122
[TBL] [Abstract][Full Text] [Related]
20. Down-expression of miR-154 suppresses tumourigenesis in CD133(+) glioblastoma stem cells.
Yang L; Yan Z; Wang Y; Ma W; Li C
Cell Biochem Funct; 2016 Aug; 34(6):404-13. PubMed ID: 27338789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
